These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 4917694
1. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. Skipper HE, Perry S. Cancer Res; 1970 Jun; 30(6):1883-97. PubMed ID: 4917694 [No Abstract] [Full Text] [Related]
2. [Determination of the sensitivity of leukemic blasts to cytostatic agents by means of an isotope method]. Kuliszkiewicz-Janus M. Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Jun; 108(2):213-7. PubMed ID: 6168529 [No Abstract] [Full Text] [Related]
3. Characteristics of cell proliferation in acute leukemia. Cheung WH, Rai KR, Sawitsky A. Cancer Res; 1972 May; 32(5):939-42. PubMed ID: 4502172 [No Abstract] [Full Text] [Related]
4. [In-vitro culture on agar of normal and leukemic bone marrow]. Gabutti V, Nicola P. Minerva Pediatr; 1974 Apr 28; 26(15):759-71. PubMed ID: 4533053 [No Abstract] [Full Text] [Related]
5. Factors in human serum affecting the proliferation of normal and leukemic cells. Burke PJ, Diggs CH, Owens AH. Cancer Res; 1973 Apr 28; 33(4):800-6. PubMed ID: 4512147 [No Abstract] [Full Text] [Related]
6. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Pratt CB, Roberts D, Shanks E, Warmath EL, Jackson R. Cancer Res; 1973 Sep 28; 33(9):2020-5. PubMed ID: 4516498 [No Abstract] [Full Text] [Related]
7. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents. Hirshaut Y, Weiss GH, Perry S. Cancer Res; 1969 Sep 28; 29(9):1732-40. PubMed ID: 5258874 [No Abstract] [Full Text] [Related]
8. [6-Thioguanine in the chemotherapy of leukemias]. Zidermane AA. Vopr Onkol; 1979 Sep 28; 25(1):74-83. PubMed ID: 284664 [No Abstract] [Full Text] [Related]
9. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210. Benckhuijsen C. Folia Med Neerl; 1969 Dec 02; 12(2):74-84. PubMed ID: 4894168 [No Abstract] [Full Text] [Related]
10. The generation time of human leukemic myeloblasts. Greenberg ML, Chanana AD, Cronkite EP, Giacomelli G, Schiffer LM, Stryctmans PA, Vincent PC. Lab Invest; 1972 Mar 02; 26(3):245-52. PubMed ID: 4502025 [No Abstract] [Full Text] [Related]
12. [Prediction of the response to chemotherapy in acute leukemia through in-vitro incorporation of tritiated thymidine]. Zittoun R, Bouchard M, Facquet-Danis J, Percie-Du-Sert M, Bousser J. Ann Med Interne (Paris); 1974 Nov 02; 125(11):811-6. PubMed ID: 4618066 [No Abstract] [Full Text] [Related]
13. [Current status of cytostatic therapy]. Wilmanns W. Wien Med Wochenschr; 1974 Nov 30; 124(48):699-707. PubMed ID: 4611049 [No Abstract] [Full Text] [Related]
14. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210. Young RC, DeVita VT. Cancer Res; 1970 Jun 30; 30(6):1789-94. PubMed ID: 5457940 [No Abstract] [Full Text] [Related]
15. Cell kinetics in acute lymphoblastic leukaemia. Gavosto F. Br J Haematol; 1969 Oct 30; 17(4):408. PubMed ID: 5259590 [No Abstract] [Full Text] [Related]
16. Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210. DeVita VT, Denham C, Perry S. Cancer Res; 1969 May 30; 29(5):1067-71. PubMed ID: 5781099 [No Abstract] [Full Text] [Related]
17. Leukemia and lymphoma. White LP. Geriatrics; 1970 Dec 30; 25(12):82-6. PubMed ID: 5274229 [No Abstract] [Full Text] [Related]
18. [Proliferation of bone marrow and peripheral blood cells in leukemia and under normal conditions (review of the literature)]. Kozinets GI, Rapoport GL. Probl Gematol Pereliv Krovi; 1972 Feb 30; 17(2):55-62. PubMed ID: 4558982 [No Abstract] [Full Text] [Related]
19. Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days. Clarkson B, Strife A, Fried J, Sakai Y, Ota K, Ohkita T, Masuda R. Cancer; 1970 Jul 30; 26(1):1-19. PubMed ID: 5268979 [No Abstract] [Full Text] [Related]